Sorrento Therapeutics Inc SRNE:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 05/10/24 EDT
0.0135quote price arrow down-0.0005 (-3.5714%)
Volume
102,967
52 week range
0.00 - 0.42
Loading...
  • Open0.0135
  • Day High0.016
  • Day Low0.0105
  • Prev Close0.014
  • 52 Week High0.42
  • 52 Week High Date07/20/23
  • 52 Week Low0.00
  • 52 Week Low Date04/24/24

Key Stats

  • Market Cap7.442M
  • Shares Out551.28M
  • 10 Day Average Volume157,289.6
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change-89.07

KEY STATS

  • Open0.0135
  • Day High0.016
  • Day Low0.0105
  • Prev Close0.014
  • 52 Week High0.42
  • 52 Week High Date07/20/23
  • 52 Week Low0.00
  • 52 Week Low Date04/24/24
  • Market Cap7.442M
  • Shares Out551.28M
  • 10 Day Average Volume157,289.6
  • Dividend-
  • Dividend Yield-
  • Beta1.88
  • YTD % Change-89.07

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-0.01
  • Fwd P/E (NTM)-0.03
  • EBITDA (TTM)-336.393M
  • ROE (TTM)-1,329.41%
  • Revenue (TTM)64.27M
  • Gross Margin (TTM)44.57%
  • Net Margin (TTM)-874.54%
  • Debt To Equity (MRQ)-69.28%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Sorrento Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G-MAB antibody library and targeted delivery modalities to generate the...
Henry Ji Ph.D.
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer
Address
4955 Directors Place
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
RDHL
Redhill Biopharma Ltd
0.4583+0.0003+0.0655%
MTEM
Molecular Templates Inc
1.48-0.07-4.52%
HLTH
Cue Health Inc
0.1289-0.0011-0.8462%
CDTX
Cidara Therapeutics Inc
12.16-0.44-3.49%
PLX
Protalix Biotherapeutics Inc
1.10-0.15-12.00%